Minerva Neurosciences NERV
NASDAQ NERV
$2.55 +0.06 (+2.41%)
As of: Nov 11, 2026 · 3:55 PM EST

Minerva Neurosciences (NERV) Return on Capital Employed [ROCE] (2014 - 2026)

Updated

Minerva Neurosciences (NERV) reported Return on Capital Employed [ROCE] of -38.79% for Q2 2026, up 16.81 percentage points from -55.59% a year earlier but down 8.33 percentage points from the prior quarter.

Analysis

Minerva Neurosciences (NERV) Return on Capital Employed [ROCE] (2014 - 2026) Analysis & Trends

For FY2025, Minerva Neurosciences posted Return on Capital Employed [ROCE] of -23.14%, up 26.31 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a five-year change of -26.01 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -49.45% in FY2024 (-5.54 pp), -43.91% in FY2023 (-4.93 pp), -38.98% in FY2022 (+31.29 pp) and -70.27% in FY2021 (-73.14 pp).
  • Five-year quarterly Return on Capital Employed [ROCE] spans a low of -69.04% in Q3 2022 and a high of -24.86% in Q4 2025.
  • Year over year, Return on Capital Employed [ROCE] has now increased in each of the last five quarters, with an average year-over-year change of +4.12 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q3 2023 (a gain of 35.03 percentage points); the low point was Q1 2022 (a drop of 73.04 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -30.46% (Q1 2026), -24.86% (Q4 2025) and -55.09% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Minerva Neurosciences 124.09 Mn -188.49 Mn - -44.32%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -44.32%
Jun 30, 2026 -38.79%
Mar 31, 2026 -30.46%
Dec 31, 2025 -24.86%
Sep 30, 2025 -55.09%
Jun 30, 2025 -55.59%
Mar 31, 2025 -57.74%
Dec 31, 2024 -58.83%
Sep 30, 2024 -61.14%
Jun 30, 2024 -59.30%
Mar 31, 2024 -48.07%
Dec 31, 2023 -40.79%
Sep 30, 2023 -34.02%
Jun 30, 2023 -35.06%
Mar 31, 2023 -44.44%
Dec 31, 2022 -45.02%
Sep 30, 2022 -69.04%
Jun 30, 2022 -68.11%
Mar 31, 2022 -64.92%
Dec 31, 2021 -53.67%
API Access

Minerva Neurosciences Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=NERV&period=max&api_key=YOUR_API_KEY